Can Healthy People Get Aspergillus niger Lung Infection?
At a Glance
Yes, a person without a known immune disorder can rarely develop serious Aspergillus niger lung disease, especially after lung damage, severe flu or COVID-19, critical illness, steroid use, or an unrecognized health condition. A positive test alone does not prove active infection.
In this answer
3 sections
Yes, it is possible, though uncommon. While serious Aspergillus lung infections are most often seen in people with severely weakened immune systems (such as those undergoing chemotherapy or organ transplants), people with no known immune disorder can still develop severe infections [1] [2]. In these cases, the person usually has an underlying vulnerability, such as pre-existing physical damage to the lungs, a recent severe viral illness, or unrecognized medical conditions [3] [4].
(Note: Much of the medical research focuses on Aspergillus generally, especially the more common A. fumigatus, but these diagnostic and risk principles also apply to A. niger [5] [6]. Because A. niger is a less common cause of disease, a positive test for it always requires careful evaluation to see if it is causing active illness, just colonizing the airways, or simply a contaminated sample [7] [5].)
The Spectrum of Aspergillus Lung Conditions
When the fungus affects people without a classic immune deficiency, the disease usually falls into one of these categories based on their underlying vulnerability.
1. Chronic Pulmonary Aspergillosis (CPA) and Aspergillomas
For many people who develop a serious Aspergillus infection without systemic immune suppression, the underlying cause is physical damage to the lungs [3] [8]. Prior illnesses can leave behind scars, widened airways, or empty pockets (cavities) [3] [9]. When Aspergillus spores are inhaled, they can settle and grow in these damaged spaces [10].
This can lead to:
- Aspergilloma (Fungal Ball): The fungus grows into a dense clump within an existing lung cavity [11] [3]. Some fungal balls remain stable and do not invade the lung tissue, though they can cause bleeding [11].
- Progressive CPA: A slow-growing chronic infection that actively damages the lung tissue over months or years, causing progressive cavities and worsening symptoms [11] [8].
Risk factors for these chronic conditions include:
- Prior lung infections: Especially tuberculosis (TB) or severe bacterial pneumonias that leave cavities behind [3] [12].
- Chronic lung conditions: Emphysema, COPD, or bronchiectasis (permanently widened and scarred airways) [9] [13].
- Inflammatory diseases: Conditions like sarcoidosis that cause fibrocystic changes (severe lung scarring) [9] [14].
Recent research suggests some people who develop CPA may also have subtle, unrecognized imbalances in their immune system that make it harder to clear the fungus [15] [14].
2. Invasive Pulmonary Aspergillosis (IPA)
Invasive pulmonary aspergillosis (IPA) is a faster-moving and dangerous infection where the fungus actively invades living lung tissue [7] [1]. While rare in people with normal immunity, it can occur when severe acute illness temporarily weakens the lungs’ ability to clear the fungus [2] [4].
Risk factors for invasive disease in this group include:
- Severe viral infections: Severe influenza (flu) or COVID-19 can severely alter local immune responses in the airways [2] [16].
- Critical illness: Being in the intensive care unit (ICU) or requiring mechanical ventilation (life support via a breathing machine) significantly increases risk [1] [4].
- Medications: High doses or long-term use of systemic corticosteroids (like prednisone) can suppress immunity [13] [17]. (Important: Never stop or change prescribed steroid medications without discussing it with your doctor, as abrupt changes can be dangerous).
- Unrecognized medical conditions: Uncontrolled diabetes, chronic kidney disease, or poor nutrition can compromise the body’s ability to fight off infections [1] [18].
(Note: There is also an allergic form of the disease called Allergic Bronchopulmonary Aspergillosis (ABPA), which is a severe allergic reaction to the fungus rather than an active infection, typically seen in people with asthma or cystic fibrosis.)
Diagnosis and What Happens Next
Finding Aspergillus niger on a swab or sputum culture does not automatically mean you have a serious infection [7]. The fungus is common in the environment, and it may simply be colonizing your airways (living there without causing active disease or damage) or contaminating the sample [7] [5].
To tell the difference between colonization, an aspergilloma, CPA, or IPA, doctors use a combination of tools:
- CT Scans: Used to look for patterns like cavities, nodules, or fungal balls [14] [19]. However, a CT scan alone cannot prove whether the fungus is actively invading tissue [11].
- Blood Tests: An Aspergillus-specific IgG antibody test can show if your immune system has mounted a response to the fungus [20]. This test supports a diagnosis of chronic infection but does not by itself prove active disease, nor is it the main test for invasive disease [14] [20].
- Advanced Sampling: Doctors may need to test fluid from deep in the lungs (via a procedure called bronchoscopy) using cultures, PCR, or antigen tests, and sometimes take a tissue biopsy to confirm active invasion [7] [21].
Treatment Overview:
Care is highly individualized. A stable aspergilloma might only be monitored or, if it causes significant bleeding, treated with surgery [11] [7]. Progressive CPA often requires months of specialized antifungal medications, which involve regular monitoring for liver side effects and drug interactions [22]. Invasive disease (IPA) requires urgent, aggressive treatment usually coordinated by infectious disease or pulmonary specialists [7] [22].
When to Seek Urgent Medical Care
Do not wait to see if symptoms improve if you develop serious warning signs. Seek emergency medical care immediately if you experience:
- Coughing up blood (even small amounts, but especially if it is large-volume or recurrent)
- New, severe, or rapidly worsening shortness of breath
- Chest pain
- Confusion, blue lips, or a high fever
If you have a persistent cough or unexplained fatigue that has lasted for weeks or months—especially if you have a history of lung disease—schedule an evaluation with your doctor to investigate the cause [11] [12] [10].
Common questions in this guide
Can someone with no known immune disorder develop a serious Aspergillus niger lung infection?
Does finding Aspergillus niger in sputum mean I have an active infection?
What lung problems can make Aspergillus niger disease more likely?
What symptoms of Aspergillus lung disease require emergency care?
How do doctors tell airway colonization from a serious Aspergillus lung infection?
How is a serious Aspergillus niger lung infection treated?
Should I stop taking steroids if I am worried about Aspergillus?
Related questions
Show more
Get notified when new evidence is published on Aspergillus niger infection.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (22)
- 1
Incidence, mortality and risk factors of invasive pulmonary aspergillosis in critically ill patients during the COVID-19 era: a global systematic review and meta-analysis.
Zhou Z, Luo B, Zhang X, et al.
Annals of clinical microbiology and antimicrobials 2026; (25(1)).
PMID: 42432685 - 2
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.
Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al.
The Lancet. Respiratory medicine 2018; (6(10)):782-792 doi:10.1016/S2213-2600(18)30274-1.
PMID: 30076119 - 3
Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease.
Neuböck MJ, , Günther G, et al.
Seminars in respiratory and critical care medicine 2024; (45(1)):102-113 doi:10.1055/s-0043-1776913.
PMID: 38196060 - 4
COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: a prospective, multicentre UK study.
Hurt W, Youngs J, Ball J, et al.
Thorax 2023; (79(1)):75-82 doi:10.1136/thorax-2023-220002.
PMID: 37657925 - 5
Distribution of Aspergillus species and risk factors for aspergillosis in mainland China: a systematic review.
Khan S, Bilal H, Shafiq M, et al.
Therapeutic advances in infectious disease 2024; (11()):20499361241252537 doi:10.1177/20499361241252537.
PMID: 38835831 - 6
Characteristics of culture-positive invasive pulmonary aspergillosis in patients with hematologic diseases: Comparison between Aspergillus fumigatus and non-fumigatus Aspergillus species.
Cho SY, Lee DG, Choi JK, et al.
Medicine 2017; (96(49)):e8841 doi:10.1097/MD.0000000000008841.
PMID: 29245249 - 7
Role of COPD in a case of fatal Aspergillus niger tracheobronchitis.
Ashby T, Green K, Burcher KM, Louis M
BMJ case reports 2023; (16(3)) doi:10.1136/bcr-2022-251807.
PMID: 36948520 - 8
Clinical Features, Diagnostic Test Performance, and Prognosis in Different Subtypes of Chronic Pulmonary Aspergillosis.
Zhong H, Wang Y, Gu Y, et al.
Frontiers in medicine 2022; (9()):811807 doi:10.3389/fmed.2022.811807.
PMID: 35223906 - 9
Chronic pulmonary aspergillosis and sarcoidosis.
Jeny F, Brun S, Tran Ba S, Uzunhan Y
Current opinion in pulmonary medicine 2026; (32(5)):508-517 doi:10.1097/MCP.0000000000001299.
PMID: 42471781 - 10
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.
Denning DW, Cadranel J, Beigelman-Aubry C, et al.
The European respiratory journal 2016; (47(1)):45-68 doi:10.1183/13993003.00583-2015.
PMID: 26699723 - 11
Chronic Pulmonary Aspergillosis: Clinical Presentation and Management.
Evans TJ, Lawal A, Kosmidis C, Denning DW
Seminars in respiratory and critical care medicine 2024; (45(1)):88-101 doi:10.1055/s-0043-1776914.
PMID: 38154471 - 12
Chronic pulmonary aspergillosis in patients with active pulmonary tuberculosis with persisting symptoms in Uganda.
Namusobya M, Bongomin F, Mukisa J, et al.
Mycoses 2022; (65(6)):625-634 doi:10.1111/myc.13444.
PMID: 35419885 - 13
A machine learning-based risk prediction tool for early identification of invasive pulmonary aspergillosis in immunocompetent patients: a systematic review and meta-analysis.
Liu F, Wang Z, Wu H, et al.
Journal of thoracic disease 2026; (18(1)):20 doi:10.21037/jtd-2025-aw-2135.
PMID: 41660451 - 14
Chronic Pulmonary Aspergillosis: Notes for a Clinician in a Resource-Limited Setting Where There Is No Mycologist.
Bongomin F, Asio LG, Baluku JB, et al.
Journal of fungi (Basel, Switzerland) 2020; (6(2)) doi:10.3390/jof6020075.
PMID: 32498415 - 15
Dendritic cell dysfunction, including impaired IL-12 production, is associated with chronic pulmonary aspergillosis.
Colombo SAP, Gago S, Chamula M, et al.
Clinical and experimental immunology 2025; (219(1)) doi:10.1093/cei/uxaf038.
PMID: 40503945 - 16
Invasive Pulmonary Aspergillosis after COVID-19 Pneumonia.
David F, Morais JR, Beires F, et al.
European journal of case reports in internal medicine 2022; (9(3)):003209 doi:10.12890/2022_003209.
PMID: 35402341 - 17
COVID-19-Associated Pulmonary Aspergillosis in Russia.
Shadrivova O, Gusev D, Vashukova M, et al.
Journal of fungi (Basel, Switzerland) 2021; (7(12)) doi:10.3390/jof7121059.
PMID: 34947041 - 18
Risk Factors for Invasive Pulmonary Aspergillosis in Critically Ill Patients With Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome.
Chauvet P, Mallat J, Arumadura C, et al.
Critical care explorations 2020; (2(11)):e0244 doi:10.1097/CCE.0000000000000244.
PMID: 33205046 - 19
Diagnostic performance of Aspergillus-specific immunoglobulin G immunochromatographic and enzyme-linked immunosorbent assay testing in chronic pulmonary aspergillosis: comparative analysis across subtypes and influencing factors.
Duan JL, Lu C, Jiang Y, et al.
Journal of thoracic disease 2025; (17(10)):8467-8476 doi:10.21037/jtd-2025-110.
PMID: 41229831 - 20
Improving Diagnostic Sensitivity of Chronic Pulmonary Aspergillosis Using Species-Specific IgG.
Sehgal IS, Agarwal R, Muthu V, et al.
Mycoses 2025; (68(9)):e70107 doi:10.1111/myc.70107.
PMID: 40899055 - 21
An Aspergillus luchuensis isolated from a patient with hemoptysis insights from a comprehensive genome-based analysis: Case report.
Chang K, Xie H, Wang Y, et al.
Medicine 2026; (105(35)):e50486 doi:10.1097/MD.0000000000050486.
PMID: 42675750 - 22
A rare case of invasive pulmonary aspergillosis presenting as organizing pneumonia due to Aspergillus niger in an immunocompetent host.
Schils R, Altdorfer A, Moerman F, et al.
Respiratory medicine case reports 2021; (34()):101503 doi:10.1016/j.rmcr.2021.101503.
PMID: 34485051
This page is for informational purposes only and does not constitute medical advice. A positive Aspergillus niger result should be interpreted by your clinician, and coughing up blood or severe breathing trouble warrants emergency medical care.